{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T01:39:37Z","timestamp":1774489177046,"version":"3.50.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2,1]]},"DOI":"10.2146\/ajhp110208","type":"journal-article","created":{"date-parts":[[2012,1,18]],"date-time":"2012-01-18T19:33:21Z","timestamp":1326915201000},"page":"232-240","source":"Crossref","is-referenced-by-count":13,"title":["Stability of extemporaneously prepared cytarabine, methotrexate sodium, and methylprednisolone sodium succinate"],"prefix":"10.1093","volume":"69","author":[{"given":"Matthias","family":"D\u2019Hondt","sequence":"first","affiliation":[{"name":"Master Industrial Sciences Biochemistry"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elien","family":"Vangheluwe","sequence":"additional","affiliation":[{"name":"Master Industrial Sciences Biochemistry"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Van Dorpe","sequence":"additional","affiliation":[{"name":"Master in Chemistry"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jente","family":"Boonen","sequence":"additional","affiliation":[{"name":"Drug Quality and Registration Group, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiene","family":"Bauters","sequence":"additional","affiliation":[{"name":"Production, and Hospital Pharmacist"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Pelfrene","sequence":"additional","affiliation":[{"name":"Production, and Hospital Pharmacist"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Vandenbroucke","sequence":"additional","affiliation":[{"name":"Production, and Hospital Pharmacist"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Robays","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Ghent University Hospital, Ghent"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"De Spiegeleer","sequence":"additional","affiliation":[{"name":"Faculty of Pharmaceutical Sciences, Ghent University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2019041606590739300_b1-0690232","unstructured":"European Organisation for Research and Treatment of Cancer. EORTC protocol 58081: CLG treatment guidelines for acute lymphoblastic leukemia. www.eortc.be (accessed 2011 Apr 4)."},{"key":"2019041606590739300_b2-0690232","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1182\/blood.V84.2.355.355","article-title":"Prevention and treatment of meningeal leukemia in children","volume":"84","author":"Pinkel","year":"1994","journal-title":"Blood."},{"key":"2019041606590739300_b3-0690232","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood-2005-12-011809","article-title":"Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children\u2019s Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children\u2019s Oncology Group","volume":"108","author":"Matloub","year":"2006","journal-title":"Blood."},{"key":"2019041606590739300_b4-0690232","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2165\/00128072-200103040-00001","article-title":"Intrathecal chemotherapy with antineoplastic agents in children","volume":"3","author":"Ruggiero","year":"2001","journal-title":"Paediatr Drugs."},{"key":"2019041606590739300_b5-0690232","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood.V50.3.471.471","article-title":"Combination intrathecal therapy for meningeal leukemia: two versus three drugs","volume":"50","author":"Sullivan","year":"1977","journal-title":"Blood."},{"key":"2019041606590739300_b6-0690232","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00685544","article-title":"A review of the stability and compatibility of antineoplastic drugs for multiple-drug infusions","volume":"31","author":"Williams","year":"1992","journal-title":"Cancer Chemother Pharmacol."},{"key":"2019041606590739300_b7-0690232","unstructured":"European Medicines Agency. ICH topc Q1B\u2014photostability testing of new active substances and medicinal products. www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500002647.pdf (accessed 2011 Mar 31)."},{"key":"2019041606590739300_b8-0690232","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.foodchem.2011.03.004","article-title":"Dry heat stress stability evaluation of casein peptide mixture","volume":"128","author":"D\u2019Hondt","year":"2011","journal-title":"Food Chem."},{"key":"2019041606590739300_b9-0690232","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1515\/zpch-1889-0116","article-title":"Uber die reaktion geschwin-digkeit bei der inversion vor Rhorzucker durch Sauren","volume":"4","author":"Arrhenius","year":"1889","journal-title":"Z Phys Chem."},{"key":"2019041606590739300_b10-0690232","first-page":"2485","volume-title":"European Pharmacopoeia 7.0","year":"2011"},{"key":"2019041606590739300_b11-0690232","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jps.2600700217","article-title":"Initial rate studies of hydrolysis and acyl migration in methylprednisolone 21-hemisuccinate and 17-hemisuccinate","volume":"70","author":"Anderson","year":"1981","journal-title":"J Pharm Sci."},{"key":"2019041606590739300_b12-0690232","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0731-7085(98)00308-2","article-title":"Simultaneous analysis of dextran-methylprednisolone succinate, methylprednisolone succinate, and methylprednisolone by size-exclusion chromatography","volume":"19","author":"Mehvar","year":"1999","journal-title":"J Pharm Biomed Anal."},{"key":"2019041606590739300_b13-0690232","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jpba.2009.09.041","article-title":"A rapid and sensitive LC-ESI-MS\/MS method for detection and quantification of methyl-prednisolone and methylprednisolone acetate in rat plasma after intra-articular administration","volume":"51","author":"Panusa","year":"2010","journal-title":"J Pharm Biomed Anal."},{"key":"2019041606590739300_b14-0690232","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00216-011-4744-6","article-title":"Uninary profile of methylprednisolone acetate metabolites in patients following intra-articular and intramuscular administration","volume":"400","author":"Panusa","year":"2011","journal-title":"Anal Bioanal Chem."},{"key":"2019041606590739300_b15-0690232","first-page":"402","article-title":"Evaluation of some pharmaceutical aspects of intrathecal methotrexate sodium, cytarabine and hydrocortisone sodium succinate","volume":"35","author":"Cradock","year":"1978","journal-title":"Am J Hosp Pharm."},{"key":"2019041606590739300_b16-0690232","first-page":"1802","article-title":"Stability of cytarabine, methotrexate sodium, and hydrocortisone sodium succinate admixtures","volume":"41","author":"Cheung","year":"1984","journal-title":"Am J Hosp Pharm."},{"key":"2019041606590739300_b17-0690232","first-page":"965","article-title":"Physical and chemical stability of methotrexate sodium, cytarabine, and hydrocortisone sodium succinate in Elliott\u2019s B solution","volume":"31","author":"Zhang","year":"1996","journal-title":"Hosp Pharm."},{"key":"2019041606590739300_b18-0690232","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1191\/1078155202jp087oa","article-title":"Physical and chemical stability of methotrexate, cytarabine, and hydrocortisone in Elliott\u2019s B solution for intrathecal use","volume":"8","author":"Trissel","year":"2002","journal-title":"J Oncol Pharm Pract."},{"key":"2019041606590739300_b19-0690232","volume-title":"Solu-Medrol (methylprednisolone sodium succinate) package insert","year":"2009"},{"key":"2019041606590739300_b20-0690232","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0378-5173(83)90051-0","article-title":"Kinetics of degradation of methotrexate in aqueous solution","volume":"16","author":"Hansen","year":"1983","journal-title":"Int J Pharm."},{"key":"2019041606590739300_b21-0690232","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0378-5173(95)04242-3","article-title":"Stability and compatibility of 2.5 mg\/ mL methotrexate solution in plastic syringes over 7 days","volume":"128","author":"Jacolot","year":"1996","journal-title":"Int J Pharm."},{"key":"2019041606590739300_b22-0690232","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.chemosphere.2010.03.032","article-title":"Oxidation kinetics of cyclophosphamide and methotrexate by ozone in drinking water","volume":"79","author":"Garcia-Ac","year":"2010","journal-title":"Chemosphere."},{"key":"2019041606590739300_b23-0690232","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0378-5173(96)04851-X","article-title":"Stability of principal cytostatic agents during storage at unusual temperatures","volume":"149","author":"Martel","year":"1997","journal-title":"Int J Pharm."},{"key":"2019041606590739300_b24-0690232","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/jps.2600670422","article-title":"Thermal and photolytic decomposition of methotrexate in aqueous solutions","volume":"67","author":"Chatterji","year":"1978","journal-title":"J Pharm Sci."},{"key":"2019041606590739300_b25-0690232","first-page":"2955","volume-title":"The United States pharmacopeia, 32nd rev., and The national formulary, 27th ed","year":"2009"},{"key":"2019041606590739300_b26-0690232","first-page":"2928","volume-title":"The United States pharmacopeia, 32nd rev., and The national formulary, 27th ed","year":"2009"},{"key":"2019041606590739300_b27-0690232","first-page":"2467","volume-title":"European Pharmacopoeia 7.0","year":"2011"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/69\/3\/232\/28455654\/ajhp0232.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:31:44Z","timestamp":1593563504000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/69\/3\/232\/5112107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,1]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,2,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp110208","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,2,1]]},"published":{"date-parts":[[2012,2,1]]}}}